U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H30N4O2S.ClH.2H2O
Molecular Weight 499.066
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PEROSPIRONE HYDROCHLORIDE DIHYDRATE

SMILES

O.O.Cl.[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN3CCN(CC3)C4=NSC5=C4C=CC=C5)C2=O

InChI

InChIKey=LZQKLGXZZSMREH-SMMZMSQNSA-N
InChI=1S/C23H30N4O2S.ClH.2H2O/c28-22-17-7-1-2-8-18(17)23(29)27(22)12-6-5-11-25-13-15-26(16-14-25)21-19-9-3-4-10-20(19)30-24-21;;;/h3-4,9-10,17-18H,1-2,5-8,11-16H2;1H;2*1H2/t17-,18+;;;

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C23H30N4O2S
Molecular Weight 426.575
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12054062

Perospirone (Lullan®) is an atypical antipsychotic of the azapirone family. It is used in Japan for the treatment of schizophrenia and acute cases of bipolar mania. Its primary mode of action is through antagonism of serotonin 5-HT2A and dopamine D2 receptors.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.6 nM [Kd]
0.09 nM [Kd]
1.3 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
LULLAN

Approved Use

For the treatment of schizophrenia and acute cases of bipolar mania.

Launch Date

2000
Palliative
LULLAN

Approved Use

For the treatment of schizophrenia and acute cases of bipolar mania.

Launch Date

2000
PubMed

PubMed

TitleDatePubMed
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
1975 Nov
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
1992 Apr 10
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
1998 Mar
Patents

Sample Use Guides

The recommended dose is 4 mg three times daily taken after meals, and daily dose should not exceed 48 mg.
Route of Administration: Oral
In Vitro Use Guide
The binding affinity of perospirone (SM-9018) for various neurotransmitter and drug-receptors was investigated in the rat brain. SM-9018 possessed very high affinity for 5-HT2, D2 and 5-HT1A receptors (Ki = 0.61, 1.4 and 2.9 nM, respectively), and it had moderate affinity for alpha 1 and D1 receptors (Ki = 17 and 41 nM, respectively). However, SM-9018 had only negligible affinity for alpha 2, opiate, glutamate, phencyclidine, benzodiazepine and GABA-A receptors.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:12:49 GMT 2023
Edited
by admin
on Fri Dec 15 19:12:49 GMT 2023
Record UNII
S03S4466IP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PEROSPIRONE HYDROCHLORIDE DIHYDRATE
WHO-DD  
Common Name English
CIS-N-(4-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)BUTYL)-1,2-CYCLOHEXANEDICARBOXIMIDE HYDROCHLORIDE DIHYDRATE
Common Name English
1H-ISOINDOLE-1,3(2H)-DIONE, 2-(4-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)BUTYL)HEXAHYDRO-, HYDROCHLORIDE, HYDRATE (1:1:2), (3AR,7AS)-REL-
Common Name English
Perospirone hydrochloride dihydrate [WHO-DD]
Common Name English
PEROSPIRONE HYDROCHLORIDE HYDRATE [JAN]
Common Name English
PEROSPIRONE HYDROCHLORIDE HYDRATE
JAN  
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70172763
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
FDA UNII
S03S4466IP
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
CAS
192052-81-6
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
PUBCHEM
5282504
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
EVMPD
SUB16454MIG
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
SMS_ID
100000078586
Created by admin on Fri Dec 15 19:12:49 GMT 2023 , Edited by admin on Fri Dec 15 19:12:49 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY